Quarterly Report (10-q)

Date : 05/15/2019 @ 7:17PM
Source : Edgar (US Regulatory)
Stock : Flexpoint Sensor Systems, Inc. (PC) (FLXT)
Quote : 0.099  0.0036 (3.77%) @ 10:00PM

Quarterly Report (10-q)

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549


FORM 10-Q


[X]

QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934


For quarterly period ended March 31, 2019


[   ]

TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934


For the transition period from _____ to _____


Commission file number: No. 0-24368


FLEXPOINT SENSOR SYSTEMS, INC.

(Exact name of registrant as specified in its charter)


Delaware

87-0620425

 (State of incorporation)

(I.R.S.  Employer Identification No.)

     

106 West Business Park Drive, Draper, Utah  84020

(Address of principal executive offices)


801-568-5111

(Registrant’s telephone number)


Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.

Yes [X]   No [   ]


Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).  Yes [X]   No [   ]


Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company.  See the definitions of “large accelerated filer,” “accelerated filer,”  “smaller reporting company” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

Large accelerated filer [   ]


Non-accelerated filer [X]

Accelerated filer [   ]

Smaller reporting company [X]

Emerging growth company [   ]


If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  [   ]


Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act.

Yes [   ]   No [X]


The number of shares outstanding of the registrant’s common stock was 92,863,464 as of May 15, 2018.



1




TABLE OF CONTENTS


PART I: FINANCIAL INFORMATION


Item 1.

Condensed Financial Statements

 

 

 

 

Condensed Consolidated Balance Sheets (Unaudited) at March 31, 2019 and

3

 

 

December 31, 2018

 

 

 

 

Condensed Consolidated Statements of Operations  for the Three

4

 

 

Months Ended March 31, 2019 and 2018 (Unaudited)

 

 

 

 

 

 

Condensed Statement of Stockholders’ Equity for the Three Months Ended

5

 

 

March 31, 2018 and 2019 (Unaudited)

 

 

 

 

Condensed Consolidated Statements of Cash Flows  for the

6

 

 

Three Months Ended March 31, 2019 and 2018 (Unaudited)

 

 

 

 

Notes to Condensed Consolidated Financial Statements (Unaudited)

7

 

 

Item 2.

Management’s Discussion and Analysis of Financial Condition and Results of Operations

13

 

 

Item 3.

Quantitative and Qualitative Disclosure about Market Risk

17

 

 

Item 4.

Controls and Procedures

17


PART II: OTHER INFORMATION


Item 1.  

Legal Proceedings

17

 

 

 

Item 1A.

Risk Factors

17

 

 

 

Item 2.

Unregistered Sales of Equity Securities and Use of Proceeds

18

 

 

 

Item 3.

Defaults upon Senior Securities

18

 

 

 

Item 4

Mine Safety Disclosures

18

 

 

 

Item 5.

Other Information

18

 

 

 

Item 6.

Exhibits

18

 

 

Signatures

19


PART I - FINANCIAL INFORMATION


ITEM 1.  CONDENSED FINANCIAL STATEMENTS

The financial information set forth below with respect to our condensed consolidated financial position as of March 31, 2019, the condensed consolidated statements of operations for the three months ended March 31, 2019 and 2018, the condensed consolidated statement of stockholders’ equity for the three months ended March 31, 2018 and 2019 and the condensed consolidated statements of cash flows for the three months ended March 31, 2019 and 2018 are unaudited. The information presented below for the condensed consolidated financial position as of December 31, 2018 was audited and reported as part of our annual filing of our Form 10-K, filed with Securities and Exchange Commission on April 1, 2019.  The results of operations for the three months ended March 31, 2018 and 2018, respectively, are not necessarily indicative of results to be expected for any subsequent periods.



2




FLEXPOINT SENSOR SYSTEMS, INC. AND SUBSIDIARIES

 CONDENSED CONSOLIDATED BALANCE SHEETS


 

 March 31,

2019 (Unaudited)

 

December 31, 2018

ASSETS

 

 

 

Current Assets

 

 

 

Cash and cash equivalents

$         9,148

 

 $        17,798

Accounts receivable, net of allowance for bad debts of $104,794

    and $136,761

17,383

 

            16,153

Deposits and prepaid expenses

9,903

 

            12,451

Total Current Assets

36,434

 

          46,402

Long-Term Deposits

6,550

 

              6,550

Property and Equipment, net of accumulated depreciation

 

 

 

    of $591,805 and $591,246

              5,784

 

             6,344

Patents and Proprietary Technology, net of accumulated

 

 

 

amortization of $964,582 and $957,760

9,463

 

           16,285

Goodwill

4,896,917

 

        4,896,917

Total Assets

$   4,955,148

 

 $     4,972,498

 

 

 

 

LIABILITIES AND STOCKHOLDERS' EQUITY

 

 

 

Current Liabilities

 

 

 

Accounts payable

 $      349,426

 

 $       354,422

Accounts payable – related party

53,094

 

20,000

Accrued liabilities

1,475,459

 

         1,369,946

Convertible notes payable, net of discount of $14,766 and

    $27,092

1,165,234

 

         1,102,908

Convertible notes payable to related party, net of discount of

    $3,792 and $5,032

175,721

 

            174,481

Derivative liabilities

337,152

 

284,857

Total Liabilities

3,556,086

 

    3,306,614

 

 

 

 

Stockholders' Equity

 

 

 

Preferred stock – $0.001 par value; 1,000,000 shares authorized;

 

 

 

no shares issued or outstanding

                  -

 

                  -

Common stock – $0.001 par value; 100,000,000 shares authorized;

 

 

92,863,464 shares and 92,863,464  shares issued and       outstanding,

92,863

 

            92,863

Additional paid-in capital

29,785,568

 

     29,785,568

Accumulated deficit

(28,479,369)

 

    (28,212,547)

Total Stockholders' Equity

1,399,062

 

        1,665,884

Total Liabilities and Stockholders' Equity

$  4,955,148

 

 $     4,972,498



The accompanying notes are an integral part of these condensed consolidated financial statements



3





FLEXPOINT SENSOR SYSTEMS, INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

(UNAUDITED)


 

 

For the Three Months

 

 

Ended March 31,

 

2019

 

2018

 

 

 

 

 

Manufacturing, Design and Contract Revenue

 

$ 64,595

 

$ 79,264

 

 

 

 

 

Operating Costs and Expenses

 

 

 

 

Amortization of patents and proprietary technology

 

6,822

 

8,139

Cost of revenue

 

10,793

 

18,241

Administrative and marketing expense

 

        123,926

 

       116,358

Research and development expense

 

         79,152

 

         81,877

 

 

 

 

 

Total Operating Costs and Expenses

 

       220,693

 

     224,615

 

 

 

 

 

Loss from Operations

 

(156,098)

 

(145,351)

 

 

 

 

 

Other Income and Expenses

 

 

 

 

Interest expense

 

     (76,199)

 

     (78,632)

Interest income

 

12

 

12

Gain (loss) on change in fair value of derivative liabilities

 

(34,537)

 

120,749

 

 

 

 

 

Net Other Income (Expense)

 

   (110,724)

 

    (42,129)

 

 

 

 

 

Net Loss

 

$  (266,822)

 

$  (103,222)


Basic and Diluted Loss per

Common Share

 

$       (0.00)

 

$       (0.00)

 

 

 

 

 

Basic and Diluted Weighted Average Common Shares Outstanding

 

92,863,464

 

92,863,464












  The accompanying notes are an integral part of these condensed consolidated financial statements




4





FLEXPOINT SENSOR SYSTEMS, INC. AND SUBSIDIARIES

CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY

For the Three Months Ended March 31, 2018 and 2019



 

Common

Stock

Additional

 

 

Total

 

 

 

Paid-in

 

Accumulated

Stockholder

 

Shares

Amount

Capital

 

Deficit

Equity

Balance - December 31, 2017

92,863,464

$ 92,863

$ 29,785,568

 

$  (27,306,453)

$  2,571,978

 

 

 

 

 

 

 

Net loss

-

-

-

 

(103,222)

(103,222)

 

 

 

 

 

 

 

Balance - March 31, 2018

 92,863,464

$ 92,863

   $ 9,785,568

 

 $(28,479,369)

  $2,468,756



 

Common

Stock

Additional

 

 

Total

 

 

 

Paid-in

 

Accumulated

Stockholder

 

Shares

Amount

Capital

 

Deficit

Equity

Balance - December 31, 2018

92,863,464

$ 92,863

$ 29,785,568

 

$  (28,212,547)

$  1,665,884

 

 

 

 

 

 

 

Net loss

-

-

-

 

(266,822)

(266,822)

 

 

 

 

 

 

 

Balance - March 31, 2019

 92,863,464

$ 92,863

   $ 9,785,568

 

 $(28,479,369)

  $1,399,062





























The accompanying notes are an integral part of these condensed consolidated financial statements





5




FLEXPOINT SENSOR SYSTEMS, INC. AND SUBSIDIARIES

 CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

(UNAUDITED)


 

For the Three Months

 

Ended March 31,

 

2019

 

2018

 Cash Flows from Operating Activities:  

 

 

 

    Net loss

$   (266,822)

 

$   (103,222)

    Adjustments to reconcile net loss to net cash used in operating activities:

 

 

 

        Amortization of patents and proprietary technology

6,822

 

8,139

        Amortization of discount on note payable

31,324

 

46,408

        Depreciation

560

 

560

        Gain (loss) on change in fair value of derivative liabilities

34,537

 

(120,749)

   Changes in operating assets and liabilities:

 

 

 

        Accounts receivable

(1,230)

 

41,952

        Prepaid expenses and other assets

2,548

 

(8,403)

        Accounts payable

            9,098

 

         49,297

        Accounts payable – related parties

19,000

 

-

        Accrued liabilities

105,513

 

28,279

 Net Cash Used in Operating Activities 

(58,650)

 

(57,439)

 

 

 

 

 Cash Flows from Investing Activities:  

 

 

 

 Net Cash Used in Investing Activities  

-

 

-


 Cash Flows from Financing Activities:

 

 

 

        Proceeds from bank overdraft

-

 

4,607

        Proceeds from borrowings under convertible note payable

50,000

 

40,000

 Net Cash Provided by Financing Activities  

50,000

 

44,607

 

 

 

 

 Net Change in Cash and Cash Equivalents

(8,650)

 

(12,832)

 Cash and Cash Equivalents at Beginning of Period

17,798

 

12,832

 Cash and Cash Equivalents at End of Period

$           9,148

 

$               - 

 

 

 

 

 Supplemental Cash Flow Information:

 

 

 

    Cash paid for income taxes

$                   - 

 

$               - 

    Cash paid for interest

$                   - 

 

$               - 

 

 

 

 

 Supplemental Disclosure on Noncash Investing and

   Financing Activities

 

 

 

    Recognition of discounts on convertible notes payable

$          17,758

 

$       12,449







The accompanying notes are an integral part of these condensed consolidated financial statements



6




FLEXPOINT SENSOR SYSTEMS, INC. AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(UNAUDITED)


NOTE 1 SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES


Condensed Consolidated Interim Financial Statements – The accompanying unaudited condensed consolidated financial statements include the accounts of Flexpoint Sensor Systems, Inc. (the “Company”). These financial statements are condensed and, therefore, do not include all disclosures normally required by accounting principles generally accepted in the United States of America. Therefore, these statements should be read in conjunction with the most recent annual consolidated financial statements of Flexpoint Sensor Systems, Inc. for the year ended December 31, 2018 included in the Company’s Form 10-K filed with the Securities and Exchange Commission on April 1, 2019. In particular, the Company’s significant accounting principles were presented as Note 1 to the Consolidated Financial Statements in that report. In the opinion of management, all adjustments necessary for a fair presentation have been included in the accompanying condensed consolidated financial statements and consist of only normal recurring adjustments. The results of operations presented in the accompanying condensed consolidated financial statements are not necessarily indicative of the results that may be expected for the full year ending December 31, 2019.


Nature of Operations – Flexpoint Sensor Systems, Inc. (the Company) is located in Draper, Utah. The Company’s activities to date have included acquiring equipment and enhancing technology, obtaining financing, limited production and seeking long-term manufacturing contracts. The Company’s operations are in designing, engineering, manufacturing and selling sensor technology and equipment using flexible potentiometer technology. Through March 31, 2019 the Company continued to manufacture products and sensors to fill customer orders and provide engineering and design work.


Use of Estimates – The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenue and expenses during the reporting periods.  Actual results could differ from those estimates.


Cash and Cash Equivalents – Cash and cash equivalents are considered to be cash and highly liquid securities with original maturities of three months or less.


Fair Value Measurements The fair value of a financial instrument is the amount that could be received upon the sale of an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. Financial assets are marked to bid prices and financial liabilities are marked to offer prices. The fair value should be calculated based on assumptions that market participants would use in pricing the asset or liability, not on assumptions specific to the entity. In addition, the fair value of liabilities should include consideration of non-performance risk, including the party’s own credit risk.

 

Fair value measurements do not include transaction costs. A fair value hierarchy is used to prioritize the quality and reliability of the information used to determine fair values. Categorization within the fair value hierarchy is based on the lowest level of input that is significant to the fair value measurement. The fair value hierarchy is defined into the following three categories:

 

Level 1: Quoted market prices in active markets for identical assets or liabilities.

 

Level 2: Observable inputs other than Level 1 prices such as quoted prices for similar assets or liabilities; quoted prices in markets with insufficient volume or infrequent transactions (less active markets); or model-derived valuations in which all significant inputs are observable or can be derived principally from or corroborated by observable market data for substantially the full term of the assets or liabilities.

 

Level 3: Unobservable inputs to the valuation methodology that are significant to the measurement of fair value of assets or liabilities.

 

To the extent that valuation is based on models or inputs that are less observable or unobservable in the market, the determination of fair value requires more judgment. In certain cases, the inputs used to measure fair value may fall into different levels of the fair value hierarchy. In such cases, for disclosure purposes, the level in the fair value



7




hierarchy within which the fair value measurement is disclosed and is determined based on the lowest level input that is significant to the fair value measurement.

 

The carrying value of the Company’s cash, accounts payable, short-term borrowings (including convertible notes payable), and other current assets and liabilities approximate fair value because of their short-term maturity.

 

The Company has classified the inputs used in valuing its derivative liabilities as Level 3 inputs. The Company valued its derivatives using the binomial lattice model. While the Company believes that its valuation methods are appropriate and consistent with other market participants, it recognizes that the use of different methodologies or assumptions to determine the fair value of certain financial instruments could result in a different estimate of fair value at the reporting date. The primary assumptions that would significantly affect the fair values using the methods discussed below are that of volatility and market price of the underlying common stock of the Company.


Accounts Receivable – Trade accounts receivable are recorded at the time product is shipped or services are provided including any shipping and handling fees. Contracts associated with design and development engineering generally require a deposit of 50% of the quoted price prior to the commencement of work. The deposit is considered deferred income until the entire project is completed and accepted by the customer, at which time the entire contract price is billed to the customer and the deposit applied. The Company has established an allowance for bad debts based on a historical experience and an analysis of risk associated with the account balances.  The balance in the allowance account was $104,794 and $136,761 in the periods ended March 31, 2019 and December 31, 2018, respectively.  


Inventories – The Company does not currently have inventory.  However, as production levels increase inventories will be carried on the balance sheet.  Inventories will be stated at the lower of cost or market or net realizable value. Cost is determined by using the first in, first out (FIFO) method.  


Property and Equipment Property and equipment are stated at cost.  Additions and major improvements are capitalized while maintenance and repairs are charged to operations.  Upon trade-in, sale or retirement of property and equipment, the related cost and accumulated depreciation are removed from the accounts and any gain or loss is recognized. Depreciation is computed using the straight-line method and is recognized over the estimated useful lives of the property and equipment, which range from three to ten years.


Valuation of Long-lived Assets – The carrying values of the Company’s long-lived assets are reviewed for impairment annually and whenever events or changes in circumstances indicate that they may not be recoverable. When projections indicate that the carrying value of the long-lived asset is not recoverable, the carrying value is reduced by the estimated excess of the carrying value over the projected discounted cash flows. Under similar analysis no impairment charge was taken during the period ended March 31, 2019 and during the period ended December 31, 2018.  Impairment tests will be conducted on an annual basis and, should they indicate a carrying value in excess of fair value, additional impairment charges may be required.


Intangible Assets – Costs to obtain or develop patents are capitalized and amortized over the remaining life of the patents, and technology rights are amortized over their estimated useful lives. The Company currently has the right to several patents and proprietary technology.  Patents and technology are amortized from the date the Company acquires or is awarded the patent or technology right, over their estimated useful lives, which range from 5 to 15 years.  An impairment charge is recognized if the carrying amount is not recoverable and the carrying amount exceeds the fair value of the intangible assets as determined by projected discounted net future cash flows.  Under similar analysis there was no impairment charge taken during the period ended March 31, 2019 and during year ended December 31, 2018.


Research and Development – Research and development costs are recognized as an expense during the period incurred, which is until the conceptual formulation, design, and testing of a process is completed and the process has been determined to be commercially viable.


Lease Obligations – While the Company has adopted ASC 842 the Company has no leases at the date of this report that are required to be reported under ASC 842.  As the Company enters into such leases it will record obligations under all leases it has entered into pursuant to the reporting requirements under ASC 842, allocating such obligations between current and long term.  The Company also recorded an offsetting right of use asset.  The right of use asset and lease obligation will be amortized over the respective lives of the leases.  




8




Goodwill – Goodwill represents the excess of the Company’s reorganization value over the fair value of net assets of the Company upon emergence from bankruptcy. Goodwill is not amortized, but is tested for impairment annually, or at interim periods when a triggering event occurs using a fair value approach. According to Accounting Standards Codification (or “ASC”) 350-20 Intangibles – Goodwill and Other, a fair-value-based test is applied at the overall Company level. The test compares the fair value of the Company to the carrying value of its net assets. This test requires various judgments and estimates. The fair value of the Company is allocated to the Company’s assets and liabilities based upon their fair values with the excess fair value allocated to goodwill. An impairment of goodwill is measured as the excess of the carrying amount of goodwill over the determined fair value.


Revenue Recognition – On January 1, 2018 the Company adopted ASC 606, Revenue from Contracts with Customers , and all of the related amendments (“new revenue standard”).  We have applied the new revenue standard to all contracts as of the date of the initial adoption.  The new revenue standard establishes five steps whereby a transaction is analyzed to determine if revenue has been earned and can be recognized.  The adoption of the new revenue standard did not have any effect on our financial statements.  The vast majority of our sales are made to order, for which orders we require a deposit of 50% of the value of the order.  That amount is put in a customer deposit account until the entire order has been manufactured and shipped.  At the ship date the Company has no further obligations under the contract and the revenue from the sale is recognized.


A part of our customer base is made up of international customers.  The table below allocates revenue between domestic and international customers.   The following table presents Flexpoint Sensor Systems revenues disaggregated by region and product type:


 

 

 

March 31,

 

 

 

March 31,

 

 

 

 

2019

 

 

 

 

 

2018

 

 

 

 

Consumer

Long-term

 

 

 

 

Consumer

Long-term

 

Segments

 

 

Products

Contract

Total

 

 

 

Products

Contract

Total

Domestic

 

$

16,048

-

16,048

 

 

$

48,147

-

48,147

International

 

 

48,547

-

48,547

 

 

 

31,117

-

31,117

 

 

$

64,595

-

64,595

 

 

$

79,264

-

79264

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Components

 

 

58,172

-

58,172

 

 

 

58,086

-

58,086

Engineering Services

 

 

6,423

-

6423

 

 

 

21,178

-

21,178

 

 

$

64,595

-

64,595

 

 

$

79,264

-

79,264


Basic and Diluted Loss Per Share – Basic loss per share is computed by dividing net loss by the weighted-average number of common shares outstanding during the period.  Diluted loss per share is computed by dividing net loss by the weighted-average number of common shares and dilutive potential common shares outstanding during the period. At March 31, 2019 there were outstanding common share equivalents (options and convertible notes payable) which amounted to 27,732,874 of common stock. These common share equivalents were not included in the computation of diluted loss per share as their effect would have been anti-dilutive, thereby decreasing loss per common share.


Concentrations and Credit Risk - The Company has a few major customers who represent a significant portion of revenue, accounts receivable and notes receivable.  During the three month period ended March 31, 2019, two customers represented 64% of sales and represented 93% of accounts receivable.  The Company has a strong ongoing relationship with this customer with scheduled delivery extending through the year and does not believe this concentration poses a significant risk, as their products are based entirely on the Company’s technologies.  


Income Taxes - The Company accounts for income taxes in accordance with Statement of Financial Accounting Standards Board Accounting Codification (ASC) 740: Income Taxes.  Deferred tax assets and liabilities are measured using enacted tax rates in effect for the year in which the differences are expected to reverse.  Deferred tax assets will be reflected on the balance sheet when it is determined that it is more likely than not that the asset will be realized




9




Recent Accounting Pronouncements - The Company has reviewed all recently issued, but not yet adopted, accounting standards in order to determine their effects, if any, on its consolidated results of operation, financial position and cash flows.  Based on that review, the Company believes that none of these pronouncements will have a significant effect on its current or future earnings or operations.


NOTE 2 – GOING CONCERN


The Company continues to accumulate significant operating losses and has an accumulated deficit of $28,479,369 at March 31, 2019.  These factors raise substantial doubt about the Company’s ability to continue as a going concern. The financial statements do not include any adjustments that might result from the outcome of these uncertainties.


Management is seeking additional funding to provide operating capital for its operations until such time as revenues are sufficient to sustain our level of operations.  However, there is no assurance that additional funding will be available on acceptable terms, if at all.


NOTE 3 – DERIVATIVE INSTRUMENTS


The derivative liability as of March 31, 2019, in the amount of $337,152 has a Level 3 fair value classification.

 

The following table provides a summary of changes in fair value of the Company’s Level 3 financial liabilities as of March 31, 2019 and December 31, 2018:

 

 

 

 

 

Total

 

Balance, December 31, 2017

 

 

 

 

363,680

 

Recognition of derivative liabilities upon initial valuation

 

 

 

 

92,404

 

Change in fair value of derivative liabilities

 

 

 

 

(171,227)

 

Conversions of derivative liabilities into equity instruments

 

 

 

 

-

 

Balance, December 31, 2018

 

 

 

 

284,857

 

Recognition of derivative liabilities upon initial valuation

 

 

 

 

17,758

 

Change in fair value of derivative liabilities

 

 

 

 

34,537

 

Conversions of derivative liabilities into equity instruments

 

 

 

 

-

 

Balance, March 31, 2019

 

 

 

 

337,152

 

 

During the year ended 2018 and the period ended March 31, 2019, the Company issued convertible promissory notes which are convertible into common stock. Due to the Company’s lack of authorized shares necessary to settle all convertible instruments, in accordance with ASC 815-40-25, the Company determined that the conversion features related to these notes are derivative to settle all convertible instruments.  The accounting treatment of derivative financial instruments requires that the Company record fair value of the derivatives as of the inception date of debenture and to fair value as of each subsequent reporting date.

 

At March 31, 2019, the Company marked to market the fair value of the derivatives and determined a fair value of $337,152. The Company recorded a loss from change in fair value of derivatives of $34,537 for the three month period ended March 31, 2098.  The fair value of the embedded derivatives was determined using binomial lattice model based on the following assumptions: (1) dividend yield of 0%, (2) expected volatility of 92.26% to 94.39%, (3) weighted average risk-free interest rate of 1.73% to 2.09% (4) expected life of 0.33 to 1.00 years, and (5) the quoted market price of the Company’s common stock at each valuation date.

 

In accordance ASC 840-15-25, the Company has implemented a sequencing policy with respect to all outstanding convertible instruments. The Company evaluates its contracts based upon earliest issuance date.

  

As of March 31, 2019, liabilities measured at fair value on a recurring basis are summarized as follows:


 

 

Level 1

 

 

Level 2

 

 

Level 3

 

 

Total

Derivative Liabilities

 

 

-

 

 

 

-

 

 

 

337,152

 

 

 

337,152

Total

 

$

-

 

 

$

-

 

 

$

337,152

 

 

$

337,152





10




NOTE 4 – CONVERTIBLE NOTES PAYABLE


Convertible Note Payable


At March 31, 2019 there are notes outstanding with principal balances which total $1,180,000. Of the notes, $1,140,000 are convertible notes bearing a 10% annual rate of interest (with a 15% default rate) and are convertible into shares of common stock at the rate of $0.06 to $0.07 per share.  The remaining $40,000 is a convertible note entered into on August 8, 2011 with a former Company Director.  That note was due on December 31, 2015, and bears a default interest rate of 10%.


On January 31, 2019, the Company entered into a convertible note for up to $100,000 from a third party.  The note has an annual interest rate of 10% and is secured by the Company’s equipment.  The note has a conversion feature for restricted common shares at $0.05 per share and a maturity date of August 31, 2018.  On February 28, 2019 the Company drew $50,000 against this note.


Convertible Note Payable - Related Party


At March 31, 2019 there are notes outstanding with two directors of the Company with balances of $147,257 and $32,256, respectively.  The notes bear an 8% annual rate of interest with a 12% default rate.  There are $50,000 in notes to the first officer that had due dates of December 31, 2016 and December 31, 2017, and on which interest is being calculated at the default rate.  The remaining $97,257 and $32,256 notes have due dates of December 31, 2018. All of the convertible notes issued to directors are convertible into shares of common stock at the rate of $0.07 per share.


NOTE 5 STOCK OPTION PLANS


On August 25, 2005, the Board of Directors of the Company approved and adopted the 2005 Stock Incentive Plan (the Plan). The Plan became effective upon its adoption by the Board and will continue in effect for ten years, unless terminated.  This plan was approved by the stockholders of the Company at their annual meeting of shareholders on November 22, 2005. Under the Plan, the exercise price for all options issued will not be less than the average quoted closing market price of the Company’s trading common stock for the thirty day period immediately preceding the grant date plus a premium of ten percent.  The maximum aggregate number of shares that may be awarded under the plan is 2,500,000 shares.   The Company continues to utilize the Black-Scholes option-pricing model for calculating the fair value of the options granted as defined by ASC Topic 718, which is an acceptable valuation approach under ASC 718. This model requires the input of subjective assumptions, including the expected price volatility of the underlying stock.


On August 24, 2015, the Board of Directors approved the issuance of options to purchase 2,185,000 shares of the Company’s common stock.  Of the total issued, 1,960,000 options were issued to replace options held by directors and employees which were to expire and 225,000 options were issued to new employees.  Of the options issued, 640,000 have an option price of $0.14 per share, 500,000 have an option price of $0.15 per share, 995,000 have an option price of $0.20 per share, and 50,000 have an option price of $0.25 per share.  Options issued as replacement shall have immediate vesting terms. Options which are not replacements shall vest over a two year four month period in equal installments on the last day of 2015, 2016 and 2017, respectively.  We relied on an exemption from the registration requirements provided by Section 4(a)(2) of the Securities Act.


Projected data related to the expected volatility and expected life of stock options is based upon historical and other information, and notably, the Company's common stock has limited trading history. Changes in these subjective assumptions can materially affect the fair value of the estimate, and therefore, the existing valuation models do not provide a precise measure of the fair value of the Company's employee stock options.  Between August 25, 2005 and December 31, 2015, the Company granted options to employees to purchase an aggregate 3,096,000 shares of common stock at exercise prices ranging from $0.14 to $2.07 per share.  The options vest over three years and expire 10 years from the date of grant.  The Company used the following assumptions in estimating the fair value of the options granted:

·

Market value at the time of issuance – Range of $0.14 to 2.07

·

Expected term – Range of 3.7 years to 10.0 years

·

Risk-free interest rate – Range of 1.60% to 4.93%

·

Dividend yield – 0%

·

Expected volatility – 200% to 424%



11




·

Weighted-average fair value - $0.16 to $2.07


All of the options were fully vested at December 31, 2018. As a result there was no stock-based compensation expenses recorded for the three months ended March 31, 2019.  The Company recognized no stock-based compensation expense for the three month period ended March 31, 2018. There were 2,185,000 and 2,185,000 employee stock options outstanding at March 31, 2019 and December 31, 2018, respectively.  


A summary of all employee options outstanding and exercisable under the plan as of March 31, 2018, and changes during the three months then ended is set forth below:


Options

Shares

Weighted Average Exercise Price

Weighted Average Remaining Contractual  Life (Years)

Aggregate Intrinsic Value

 

 

 

 

 

Outstanding at the beginning of period

         2,185,000

 $                0.17

             7.65

 $              --   

   Granted

--

--

                   --

                 --   

   Expired

                     --

                             --

                   --

                 --   

   Forfeited

--

--

                   --

                --   

Outstanding at the end of Period

       2,185,000

 $                 0.17

             7.41

$               --   

Exercisable at the end of Period

2,185,000

 $                 0.17

             7.41

$               --   


NOTE 6 – CAPITAL STOCK


Preferred Stock – There are 1,000,000 shares of preferred stock with a par value of $0.001 per share authorized.  At March 31, 2019 and December 31, 2018, there were no shares of preferred stock issued or outstanding.


Common Stock – There are 100,000,000 shares of common stock with a par value of $0.001 per share authorized.  At the annual meeting of stockholders held December 28, 2018, the shareholders approved increasing the number of authorized shares to 200,000,000.  As of the date of this report the amendment to the Articles of Incorporation affecting such change has not been filed with the State of Delaware.  No shares of stock were issued during the three months ended March 31, 2019.  


NOTE 7 – COMMITMENTS AND CONTINGENCIES


The Company currently occupies manufacturing facility in Draper, Utah.  The lease on the facility expired on December 31, 2014, at which time the Company entered into a three year extension which expired on December 31, 2017.  The lease provides that on the expiration of the lease on December 31, 2017 the lease becomes a month to month lease at a rate of the current monthly lease rate ($9,600), plus an increase of 10% on the anniversary date of each succeeding year.  The Company is paying a lease rate of $11,620 per month in 2019.  Either party may terminate the lease upon 90 day written notice.


NOTE 8 – RELATED PARTY TRANSACTIONS


At March 31, 2019 and December 31, 2018, the Company had amounts of $31,094 and $10,000 payable to its Chief Executive Officer and $22,000 and $10,000 payable to a director for funds loaned the Company to pay of various operating expenses of the business.


At March 31, 2019 and December 31, 2018, the Company had outstanding notes payable to an officer in the amount of $147,257 and an outstanding note payable to a director in the amount of $32,256.


NOTE 9 – SUBSEQUENT EVENTS


On April 24, 2019 Mr. Mower, an officer of the company, made a $4,000 loan to the Company.


In accordance with ASC 855-10 management reviewed all material events through the date of this report.  There are no material subsequent events to report other than those disclosed above.



12




In this quarterly report references to “Flexpoint", "the Company," “we,” “us,” and “our” refer to Flexpoint Sensor Systems, Inc. and its subsidiaries.


FORWARD LOOKING STATEMENTS


The U.S. Securities and Exchange Commission (“SEC”) encourages reporting companies to disclose forward-looking information so that investors can better understand future prospects and make informed investment decisions.  This report contains these types of statements. Words such as “may,” “expect,” “believe,” “anticipate,” “estimate,” “project,” or “continue” or comparable terminology used in connection with any discussion of future operating results or financial performance identify forward-looking statements.  You are cautioned not to place undue reliance on the forward-looking statements, which speak only as of the date of this report.  All forward-looking statements reflect our present expectation of future events and are subject to a number of important factors and uncertainties that could cause actual results to differ materially from those described in the forward-looking statements.



ITEM 2.  MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS


EXECUTIVE OVERVIEW


Flexpoint Sensor Systems, Inc. is a company engaged principally in improving its unique sensor technology, expanding its suite of products, developing new sensor applications, obtaining financing and seeking long-term sustainable manufacturing contracts.  Our operations have not yet commenced to a commercially sustainable level and include designing, engineering, manufacturing and selling sensor technology and products featuring our Bend Sensor ® technology and equipment.


In the rapidly growing and emerging wearables space, Flexpoint has also recently received additional purchase orders from multiple glove manufacturers across various market sub-segments, including medical, toys, gaming and virtual reality.  The “speed to market” commercialization plans of these companies are driving this increased order volume.  Flexpoint is aggressively going after this evolving market, and expects this pattern to continue and dramatically increase in 2019.  In aggregate, Bend Sensor ® wearables order volumes are expected to number in the tens of thousands in 2019.  The wearables market segment is clearly one where our technology is easily adapted and truly illustrates our technological differentiation.  Flexpoint’s willingness and ability to customize sensors for these innovative companies and deliver them at a competitive price point allows us to deliver real value to our customers.


These ground-breaking glove systems, combined with unique, leading edge software applications, also adapt to a wide range of other applications, including health rehabilitation, unmanned systems control, smartphone interaction and professional training across multiple industries.  In addition to producing an array of Bend Sensors ® , the Company is under agreement to supply integrated assemblies comprised of multiple sensor types and associated electronics.


In the VR/VA marketspace, orders of increasing size and frequency were received during the fourth quarter of 2018 and in the first quarter of 2019 from Manus VR and Neofect as they strive to fulfill production orders.  Flexpoint also received orders from other global VR/AR customers during the quarter.


On October 18, 2018, the Company announced it had signed a five year manufacturing and supply agreement with Counted LLC.  Counted LLC conceived of a medication delivery monitoring system and dispensing monitoring system.  Flexpoint designed and produced the monitoring system with Flexpoint features, Flexpoint technology and Flexpoint designed electronics to track and report the dispensing of medications in real time.  The information has the potential to be transmitted to physicians, pharmacists and government agencies.  Prototypes have been built and successfully tested with additional production and testing continuing through 2018 and the first quarter of 2019.  The Company expects that commercial production will begin in the late second or third quarter of 2019, increasing throughout 2019 and beyond.


Finalizing long-term, constant revenue generating production contracts with our existing and other customers remains our greatest challenge because our on-going business is dependent on the types of revenues and cash flows generated by such contracts. Cash flow and cash requirement risks are closely tied to and are dependent upon our ability to attract significant long-term production contracts.  We must continue to obtain funding to operate and



13




expand our operations so that we can deliver our unique Bend Sensor ® and Bend Sensor ® related technologies and products to the market.  Management believes that even though we are making positive strides forward with our business plan we will need to raise additional operating capital.


LIQUIDITY AND CAPITAL RESOURCES


Currently our revenue is primarily from product manufacturing and recurring sales with additional contributions to income from design contract, testing and limited production services for prototypes and samples, and is not to a level to support our operations.  However, we believe, based upon current orders and projected orders over the next twelve months, that we could be producing sensors under long-term contracts that will help support our existing operations and potential future growth. Management recognizes such contracts usually go through a long negotiation process and there can be no guarantee that we will be successful in our negotiations or that such contracts will be sufficient to support our current operations in the near future.


For the past twelve months we have relied on the proceeds of convertible loans from existing shareholders and private placements of our common stock.  During 2018 and the first quarter of 2019, the Company secured financing to fund its operations by issuing additional convertible notes to First Equity Holdings LLC and officers, the balances of which have a combined total of $1,395,513 as of March 31, 2019. The notes have an annual interest rate of 8% to 10% and default rates of 12% to 15%, have various maturity dates, and are secured by the Company’s business assets.


Management believes that our current cash burn rate is approximately $65,000 per month and that proceeds from additional convertible notes and estimated revenues for manufacturing, production, engineering design and prototype products will be sufficient to fund the next twelve months of operations.  Our auditors have expressed doubt about our ability to continue as a going concern and that we may not realize significant revenue or become profitable within the next twelve months. We will require additional financing to fund our short-term cash needs. We will have to rely on additional debt financing, loans from existing shareholders and private placements of common stock for additional funding. Based upon our current purchase orders and anticipated purchase orders over the next twelve months our projected revenues by the end of 2019 are anticipated to cover our projected operating expenses, based on our current burn rate. However, we cannot assure you that we will be able to obtain short-term financing, or that sources of such financing, if any, will continue to be available, and if available, that they will be on terms favorable to us. Nor is there any guarantee that the projected volume of purchase orders will meet the volumes that we anticipate.


As we enter into new agreements, we must ensure that those agreements provide adequate funding for any pre-production research and development and manufacturing costs. If we are successful in establishing agreements with adequate initial funding, management believes that our operations for the long term will be funded by revenues, licensing fees and/or royalties related to these agreements. However, we have formalized only a few agreements during the past four years and there can be no assurance that the agreements will generate sufficient revenues or be profitable in the future or that a desired technological application will be successful enough to produce the volumes and profits necessary to fund our operations.  


FINANCIAL OBLIGATIONS AND CONTINGENT LIABILITIES


Our principal commitments at March 31, 2019 consisted of our operating lease of $11,620 per month, and total liabilities of $3,556,087, which includes $1,340,955 of convertible notes payable, net of discounts of $18,558.  Accrued liabilities at March 31, 2019, were $1,475,459 and were related to payroll, payroll tax liabilities, accrued professional expenses, accrued insurance expense, accrued interest expense on notes and accrued paid time off.  


During the three months ending March 31, 2019, the Company has raised an additional $50,000 in operating capital through the issuance of a short-term note.  On January 31, 2019, the Company entered into this convertible note for up to $100,000 from a third party.  The note has an annual interest rate of 10% and a default rate of 15% annually.  The note is secured by the Company’s equipment.  The note has a conversion feature for restricted common shares at $0.05 per share and a maturity date of August 31, 2018. As of March 31, 2019 the Company had only drawn $50,000 on the note.


During the year ended 2018 and the period ended March 31, 2019, the Company issued convertible promissory notes which are convertible into common stock. Due to the Company’s lack of authorized shares necessary to settle all convertible instruments, we determined that the conversion features related to these notes are derivative



14




instruments.  At March 31, 2019, the Company determined a fair value of $337,152 for the derivative instruments. The Company recorded a loss from change in fair value of derivatives of $34,537 for the three month period ended March 31, 2019.


The Company has a few major customers who represent a significant portion of revenue and accounts receivable. During the three months ended March 31, 2019, two customers represented 64% of sales and represented 93% of accounts receivable.  The Company has a strong ongoing relationship with this customer with scheduled delivery extending through the year and does not believe this concentration poses a significant risk, as their products are based entirely on the Company’s technologies


OFF-BALANCE SHEET ARRANGEMENTS


Other than our current operating lease, we have not entered into any off-balance sheet arrangements that have or are reasonably likely to have a current or future effect on our financial condition, changes in financial condition, revenues or expenses, results of operations, liquidity, capital expenditures or capital resources and would be considered material to investors.


CRITICAL ACCOUNTING ESTIMATES


The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the amounts reported in the consolidated financial statements and accompanying notes. Estimates of particular significance in our financial statements include goodwill and the annual tests for impairment of goodwill and long-lived assets and valuing stock option compensation.  


The Company's goodwill represents the excess of its reorganization value over the fair value of the net assets upon emergence from bankruptcy. Goodwill is not amortized, therefore we test our goodwill for impairment annually or when a triggering event occur using a fair value approach. A fair value based test is applied at the overall Company level. The test compares the fair value of the Company to the carrying value of its nets assets. The test requires various judgments and estimates. During 2018 and for the three months ending March 31, 2019, the Company recorded no impairment charge to reduce the carrying value of the goodwill to its estimated fair value. As part of the impairment testing performed at December 31, 2018, the Company considered factors such as the global market volatility, variables in the economy, and the overall uncertainty in the markets which has resulted in a decline in the market price of the Company's stock price and market capitalization for a sustained period, as indicators for potential goodwill impairment.


We test long-lived assets for impairment annually or when a triggering event occurs. Impairment is indicated if undiscounted cash flows are less than the carrying value of the assets. The amount of impairment is measured using a discounted-cash-flows model considering future revenues, operating costs and risk-adjusted discount rate and other factors. The analysis compares the present value of projected net cash flows for the remaining current year and next two years against the carrying value of the long-lived assets. If the carrying values of the long-lived assets exceed the present value of the discounted projected revenues an impairment expense would be recognized in the period and the carrying value of the assets would be adjusted accordingly. Impairment tests are conducted on an annual basis and, should they indicate a carrying value in excess of fair value, a charge may be required.


Financial accounting standards require that recognition of the cost of employee services received in exchange for stock options and awards of equity instruments be based on the grant-date fair value of such options and awards and is recognized as an expense in operations over the period they vest. The fair value of the options we have granted is estimated at the date of grant using the Black-Scholes American option-pricing model. Option pricing models require the input of highly sensitive assumptions, including expected stock volatility. Also, our stock options have characteristics significantly different from those of traded options, and changes in the subjective input assumptions can materially affect the fair value estimate.  Management believes the best input assumptions available were used to value the options and that the resulting option values are reasonable. For the three month periods ended March 31, 2019 and 2018 we recognized $0 and $0, respectively, of stock-based compensation expense for our stock options and there is no additional unrecognized compensation cost related to employee stock options at the current time.


RESULTS OF OPERATIONS


The following discussions are based on the consolidated operations of Flexpoint Sensor Systems, Inc. and should be read in conjunction with our unaudited financial statements for the three months ended March 31, 2019 and 2018,



15




included in Part I, Item 1, above, and the audited financial statements included in the Company’s annual report on Form 10-K for the years ended December 31, 2018 and 2017.


THREE MONTH PERIODS ENDED MARCH 31, 2019 AND 2018:

 

SUMMARY OF OPERATING RESULTS

 


Three month period ended

 

March 31, 2019

 

March 31, 2018

Manufacturing, design, and contract revenue

$            64,595

 

$            79,264

Total operating costs and expenses

220,693

 

224,615

Net other income (expense)

(110,724)

 

(42,129)

Net loss

(266,822)

 

(103,222)

Basic and diluted loss per common share

(0.00)

 

(0.00)


For the three months ending March 31, 2019 revenue was $64,595, a decrease of $14,669 when compared to the same period in 2018. The majority of the revenue for this period came from product manufacturing and recurring sales with additional contributions to income from development engineering, prototype and pre-production products. The Company continues to concentrate its marketing resources on a limited number of customers that have the greatest potential to generate the most short-term revenue while still building relationships with our larger customers.

 

Management believes this approach has the highest potential to bring long-term commercially viable products to market and will provide sustainable cash flow to fund the Company's operations in the future. Currently, overall revenues are not sufficient to sustain our operations.  Management anticipates that revenues will increase as we continue to execute our long-term business plan and cultivate larger customer bases with our existing product offering. However, until a long-term production contract is in place there is no guarantee that our current customer base will order in sufficient volumes to sustain our operations. Therefore, management continues to work with larger companies and industries and is hopeful that in the near future we will sign a long-term licensing or manufacturing contract.

 

We received revenue from repeat orders from our existing customers, design contract, and development engineering. Revenue is recognized using the ASC 606 five step detailed in Note 1 to the financial statements.  Revenue from the sale of a product is recorded at the time of shipment to the customer.  Revenue from research and development engineering contracts is recognized as the services are provided and accepted by the customer. Revenue from contracts to license technology to others is deferred until all conditions under the contract are met and then the sale is recognized as licensing royalty revenue over the remaining term of the contract.

 

Of the $220,693 and $224,615 total operating costs and expense for the three months ending March 31, 2019 and 2018, respectively, $79,152 and $81,877 were for direct research and development cost, respectively. For the three months ended March 31, 2019, total operating expenses decreased by $3,922 when compared to the same period in 2018, due primarily to a reduction in cost of revenue.  


Other expense for the three month period ended March 31, 2019 was $110,724, a $68,595 increase compared to the same period in 2018.  The increase is attributable to a loss on the change in fair value of derivative liabilities, offset in part by lower interest expense.


A net loss of $266,822 was realized for the three months ended March 31, 2019.  A net loss of $103,222 was realized for the three month period ended March 31, 2018.


The chart below represents a summary of our condensed consolidated balance sheets at March 31, 2019 and December 31, 2018.


SUMMARY OF BALANCE SHEET INFORMATION

 

 

 

 

 

March 31, 2019

 

December 31, 2018

Cash and cash equivalents

$                9,148 

 

$                17,798 

Total current assets

36,434 

 

46,402 

Total assets

            4,955,148

 

            4,972,498

Total liabilities

              3,556,086

 

              3,306,614

Accumulated deficit 

         (28,479,369)

 

         (28,212,547)

Total stockholder’s equity

 $           1,399,062

 

 $           1,665,884


 

16


Cash and cash equivalents decreased by $8,650 at March 31, 2019 compared to December 31, 2018. The decrease in cash is due to the timing of payment of expenses, collection of accounts receivable and proceeds from borrowings. Our non-current assets decreased at March 31, 2019 due to the amortization of long-lived assets.


Total liabilities increased by $249,473 at March 31, 2019.  The increase was due primarily to the funding of operations through the issuance of convertible notes payable, the accrued interest related to those notes, accruals for investor relations and insurance expenses and an increase in the derivate liability..


INFLATION


We do not expect the impact of inflation on our operations to be significant for the next twelve months.



ITEM 3.  QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK


Not applicable to smaller reporting companies.



ITEM 4.  CONTROLS AND PROCEDURES


(a)

Disclosure Controls and Procedures


As of the end of the period covered by this quarterly report we carried out an evaluation of the effectiveness of our disclosure controls and procedures under the supervision and with the participation of our Chief Executive Officer, who also serves as our Principal Financial Officer.  Our controls and procedures are designed to allow information required to be disclosed in our reports to be recorded, processed, summarized and reported within the specified periods, and accumulated and communicated to management to allow for timely decisions regarding required disclosure of material information.  Our disclosure controls and procedures are designed to provide reasonable assurance of achieving their objectives.  Based upon the evaluation, our Chief Executive Officer concluded that our disclosure controls and procedures were not effective at that reasonable assurance level as of the end of the period March 31, 2019.  


The material weaknesses relate to the limited number of persons responsible for the recording and reporting of financial information, the lack of separation of financial reporting duties, and the limited size of our management team in general. We are in the process of evaluating methods of improving our internal control over financial reporting, including the possible addition of financial reporting staff and the increased separation of financial reporting responsibility, and intend to implement such steps as are necessary and possible to correct these material weaknesses


(b)

Changes in Internal Control over Financial Reporting


There have been no changes in internal control over financial reporting during the first quarter of 2019 that have materially affected, or are reasonably likely to materially affect our internal control over financial reporting.



PART II - OTHER INFORMATION


ITEM 1. LEGAL PROCEEDINGS


None.



ITEM 1A.  RISK FACTORS


We are a smaller reporting company as defined by Rule 12b-2 of the Securities Exchange Act of 1934 and, as such, are not required to provide the information under this Item.



17




ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS


The Company has not issued any securities since the year ended December 31, 2017.



ITEM 3.  DEFAULTS UPON SENIOR SECURITIES


None.



ITEM 4.  MINE SAFETY DISCLOSURES


Not applicable.



ITEM 5.  OTHER INFORMATION


None.



ITEM 6. EXHIBITS


Part I Exhibits


No.

Description

31.1

Certification of Clark M. Mower pursuant to Section 302 of the Sarbanes-Oxley Act of 2002

31.2

Certification of Clark M. Mower pursuant to Section 302 of the Sarbanes-Oxley Act of 2002

32

Certification pursuant to 18 U.S.C. Section 1350 as adopted pursuant to Section 906 of the Sarbanes-Oxley


Part II Exhibits


No.

Description

3.1

Certificate of Incorporation of Flexpoint Sensor, as amended (Incorporated by reference to exhibit 3.1 for Form 10-QSB, filed August 4, 2006)

3.2

Bylaws of Flexpoint Sensor, as amended (Incorporated by reference to exhibit 3.4 of Form 10-QSB, filed May 3, 2004)

10.1

Addendum to Lease Agreement between Flexpoint Sensor and Handstands, dated January 1, 2015.  (Incorporated by reference to exhibit 10.3 of Form 10-K, filed April 14, 2016)

101.INS

XBRL Instance Document

101.SCH

XBRL Taxonomy Extension Schema Document

101.CAL

XBRL Taxonomy Calculation Linkbase Document

101.DEF

XBRL Taxonomy Extension Definition Linkbase Document

101.LAB

XBRL Taxonomy Label Linkbase Document

101.PRE

XBRL Taxonomy Presentation Linkbase Document





18




SIGNATURES


In accordance with the requirements of the Exchange Act, the registrant caused this report to be signed on its behalf by the undersigned, who is duly authorized.


FLEXPOINT SENSOR SYSTEMS, INC.


Date:   May 15, 2019


/s/ Clark M. Mower

Clark M. Mower

President, Chief Executive Officer and Director,

Principal Financial Officer



19



Flexpoint Sensor Systems, Inc. (PC) (OTCBB:FLXT)
Historical Stock Chart

1 Year : From Oct 2018 to Oct 2019

Click Here for more Flexpoint Sensor Systems, Inc. (PC) Charts.

Flexpoint Sensor Systems, Inc. (PC) (OTCBB:FLXT)
Intraday Stock Chart

Today : Friday 18 October 2019

Click Here for more Flexpoint Sensor Systems, Inc. (PC) Charts.

Latest FLXT Messages

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts


Your Recent History
LSE
GKP
Gulf Keyst..
LSE
QPP
Quindell
FTSE
UKX
FTSE 100
LSE
IOF
Iofina
FX
GBPUSD
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.


NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.